Part 1
Part 2
Part 3
Part 5
Market Analysis and Insights: Global and United States Intranasal Drug Delivery System Market This report focuses on global and United States Intranasal Drug Delivery System market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Intranasal Drug Delivery System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Nasal Drops accounting for % of the Intranasal Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period. In United States the Intranasal Drug Delivery System market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. Global Intranasal Drug Delivery System Scope and Market Size Intranasal Drug Delivery System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Intranasal Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Intranasal Drug Delivery System market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States. Segment by Type Nasal Drops Nasal Sprays Nasal Gels Nasal Suspensions and Emulsion Nasal Powders Segment by Application Hospital Clinic Home Care Others By Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE By Company Aptar Pharma Nemera Teleflex Mystic Pharmaceuticals Zeteo Medical Johnson & Johnson GlaxoSmithKline Plc Aegis Therapeutics LLC H&T Presspart Manufacturing Ltd. AstraZeneca Plc Becton BD Novartis AG Vectura Group Plc
1 Study Coverage
1.1 Intranasal Drug Delivery System Product Introduction
1.2 Global Intranasal Drug Delivery System Outlook 2017 VS 2022 VS 2028
1.2.1 Global Intranasal Drug Delivery System Sales in US$ Million for the Year 2017-2028
1.2.2 Global Intranasal Drug Delivery System Sales in Volume for the Year 2017-2028
1.3 United States Intranasal Drug Delivery System Outlook 2017 VS 2022 VS 2028
1.3.1 United States Intranasal Drug Delivery System Sales in US$ Million for the Year 2017-2028
1.3.2 United States Intranasal Drug Delivery System Sales in Volume for the Year 2017-2028
1.4 Intranasal Drug Delivery System Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Intranasal Drug Delivery System in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Intranasal Drug Delivery System Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Intranasal Drug Delivery System Market Dynamics
1.5.1 Intranasal Drug Delivery System Industry Trends
1.5.2 Intranasal Drug Delivery System Market Drivers
1.5.3 Intranasal Drug Delivery System Market Challenges
1.5.4 Intranasal Drug Delivery System Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Intranasal Drug Delivery System Market Segment by Type
2.1.1 Nasal Drops
2.1.2 Nasal Sprays
2.1.3 Nasal Gels
2.1.4 Nasal Suspensions and Emulsion
2.1.5 Nasal Powders
2.2 Global Intranasal Drug Delivery System Market Size by Type
2.2.1 Global Intranasal Drug Delivery System Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Intranasal Drug Delivery System Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Intranasal Drug Delivery System Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Intranasal Drug Delivery System Market Size by Type
2.3.1 United States Intranasal Drug Delivery System Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Intranasal Drug Delivery System Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Intranasal Drug Delivery System Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Intranasal Drug Delivery System Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Home Care
3.1.4 Others
3.2 Global Intranasal Drug Delivery System Market Size by Application
3.2.1 Global Intranasal Drug Delivery System Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Intranasal Drug Delivery System Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Intranasal Drug Delivery System Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Intranasal Drug Delivery System Market Size by Application
3.3.1 United States Intranasal Drug Delivery System Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Intranasal Drug Delivery System Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Intranasal Drug Delivery System Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Intranasal Drug Delivery System Competitor Landscape by Company
4.1 Global Intranasal Drug Delivery System Market Size by Company
4.1.1 Top Global Intranasal Drug Delivery System Manufacturers Ranked by Revenue (2021)
4.1.2 Global Intranasal Drug Delivery System Revenue by Manufacturer (2017-2022)
4.1.3 Global Intranasal Drug Delivery System Sales by Manufacturer (2017-2022)
4.1.4 Global Intranasal Drug Delivery System Price by Manufacturer (2017-2022)
4.2 Global Intranasal Drug Delivery System Concentration Ratio (CR)
4.2.1 Intranasal Drug Delivery System Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Intranasal Drug Delivery System in 2021
4.2.3 Global Intranasal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Intranasal Drug Delivery System Manufacturing Base Distribution, Product Type
4.3.1 Global Intranasal Drug Delivery System Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Intranasal Drug Delivery System Product Type
4.3.3 Date of International Manufacturers Enter into Intranasal Drug Delivery System Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Intranasal Drug Delivery System Market Size by Company
4.5.1 Top Intranasal Drug Delivery System Players in United States, Ranked by Revenue (2021)
4.5.2 United States Intranasal Drug Delivery System Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Intranasal Drug Delivery System Sales by Players (2020, 2021 & 2022)
5 Global Intranasal Drug Delivery System Market Size by Region
5.1 Global Intranasal Drug Delivery System Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Intranasal Drug Delivery System Market Size in Volume by Region (2017-2028)
5.2.1 Global Intranasal Drug Delivery System Sales in Volume by Region: 2017-2022
5.2.2 Global Intranasal Drug Delivery System Sales in Volume Forecast by Region (2023-2028)
5.3 Global Intranasal Drug Delivery System Market Size in Value by Region (2017-2028)
5.3.1 Global Intranasal Drug Delivery System Sales in Value by Region: 2017-2022
5.3.2 Global Intranasal Drug Delivery System Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
6.1.2 North America Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Intranasal Drug Delivery System Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
6.3.2 Europe Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
6.4.2 Latin America Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Intranasal Drug Delivery System Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Intranasal Drug Delivery System Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Aptar Pharma
7.1.1 Aptar Pharma Corporation Information
7.1.2 Aptar Pharma Description and Business Overview
7.1.3 Aptar Pharma Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Aptar Pharma Intranasal Drug Delivery System Products Offered
7.1.5 Aptar Pharma Recent Development
7.2 Nemera
7.2.1 Nemera Corporation Information
7.2.2 Nemera Description and Business Overview
7.2.3 Nemera Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Nemera Intranasal Drug Delivery System Products Offered
7.2.5 Nemera Recent Development
7.3 Teleflex
7.3.1 Teleflex Corporation Information
7.3.2 Teleflex Description and Business Overview
7.3.3 Teleflex Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Teleflex Intranasal Drug Delivery System Products Offered
7.3.5 Teleflex Recent Development
7.4 Mystic Pharmaceuticals
7.4.1 Mystic Pharmaceuticals Corporation Information
7.4.2 Mystic Pharmaceuticals Description and Business Overview
7.4.3 Mystic Pharmaceuticals Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Mystic Pharmaceuticals Intranasal Drug Delivery System Products Offered
7.4.5 Mystic Pharmaceuticals Recent Development
7.5 Zeteo Medical
7.5.1 Zeteo Medical Corporation Information
7.5.2 Zeteo Medical Description and Business Overview
7.5.3 Zeteo Medical Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Zeteo Medical Intranasal Drug Delivery System Products Offered
7.5.5 Zeteo Medical Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporation Information
7.6.2 Johnson & Johnson Description and Business Overview
7.6.3 Johnson & Johnson Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Johnson & Johnson Intranasal Drug Delivery System Products Offered
7.6.5 Johnson & Johnson Recent Development
7.7 GlaxoSmithKline Plc
7.7.1 GlaxoSmithKline Plc Corporation Information
7.7.2 GlaxoSmithKline Plc Description and Business Overview
7.7.3 GlaxoSmithKline Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.7.4 GlaxoSmithKline Plc Intranasal Drug Delivery System Products Offered
7.7.5 GlaxoSmithKline Plc Recent Development
7.8 Aegis Therapeutics LLC
7.8.1 Aegis Therapeutics LLC Corporation Information
7.8.2 Aegis Therapeutics LLC Description and Business Overview
7.8.3 Aegis Therapeutics LLC Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Aegis Therapeutics LLC Intranasal Drug Delivery System Products Offered
7.8.5 Aegis Therapeutics LLC Recent Development
7.9 H&T Presspart Manufacturing Ltd.
7.9.1 H&T Presspart Manufacturing Ltd. Corporation Information
7.9.2 H&T Presspart Manufacturing Ltd. Description and Business Overview
7.9.3 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.9.4 H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Products Offered
7.9.5 H&T Presspart Manufacturing Ltd. Recent Development
7.10 AstraZeneca Plc
7.10.1 AstraZeneca Plc Corporation Information
7.10.2 AstraZeneca Plc Description and Business Overview
7.10.3 AstraZeneca Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.10.4 AstraZeneca Plc Intranasal Drug Delivery System Products Offered
7.10.5 AstraZeneca Plc Recent Development
7.11 Becton
7.11.1 Becton Corporation Information
7.11.2 Becton Description and Business Overview
7.11.3 Becton Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Becton Intranasal Drug Delivery System Products Offered
7.11.5 Becton Recent Development
7.12 BD
7.12.1 BD Corporation Information
7.12.2 BD Description and Business Overview
7.12.3 BD Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.12.4 BD Products Offered
7.12.5 BD Recent Development
7.13 Novartis AG
7.13.1 Novartis AG Corporation Information
7.13.2 Novartis AG Description and Business Overview
7.13.3 Novartis AG Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Novartis AG Products Offered
7.13.5 Novartis AG Recent Development
7.14 Vectura Group Plc
7.14.1 Vectura Group Plc Corporation Information
7.14.2 Vectura Group Plc Description and Business Overview
7.14.3 Vectura Group Plc Intranasal Drug Delivery System Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Vectura Group Plc Products Offered
7.14.5 Vectura Group Plc Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Intranasal Drug Delivery System Industry Chain Analysis
8.2 Intranasal Drug Delivery System Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Intranasal Drug Delivery System Distributors
8.3 Intranasal Drug Delivery System Production Mode & Process
8.4 Intranasal Drug Delivery System Sales and Marketing
8.4.1 Intranasal Drug Delivery System Sales Channels
8.4.2 Intranasal Drug Delivery System Distributors
8.5 Intranasal Drug Delivery System Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables Table 1. Intranasal Drug Delivery System CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Intranasal Drug Delivery System Market Trends Table 3. Intranasal Drug Delivery System Market Drivers Table 4. Intranasal Drug Delivery System Market Challenges Table 5. Intranasal Drug Delivery System Market Restraints Table 6. Global Intranasal Drug Delivery System Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Intranasal Drug Delivery System Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Intranasal Drug Delivery System Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Intranasal Drug Delivery System Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Intranasal Drug Delivery System Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Intranasal Drug Delivery System Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Intranasal Drug Delivery System Revenue Share by Manufacturer, 2017-2022 Table 13. Global Intranasal Drug Delivery System Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Intranasal Drug Delivery System Sales Share by Manufacturer, 2017-2022 Table 15. Global Intranasal Drug Delivery System Price by Manufacturer (2017-2022) & (US$/Unit) Table 16. Global Intranasal Drug Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Intranasal Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intranasal Drug Delivery System as of 2021) Table 18. Top Players of Intranasal Drug Delivery System in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Intranasal Drug Delivery System Product Type Table 20. Date of International Manufacturers Enter into Intranasal Drug Delivery System Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Intranasal Drug Delivery System Players in United States Market, Ranking by Revenue (2021) Table 23. United States Intranasal Drug Delivery System Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Intranasal Drug Delivery System Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Intranasal Drug Delivery System Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Intranasal Drug Delivery System Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Intranasal Drug Delivery System Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Intranasal Drug Delivery System Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Intranasal Drug Delivery System Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Intranasal Drug Delivery System Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Intranasal Drug Delivery System Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Intranasal Drug Delivery System Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Intranasal Drug Delivery System Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Intranasal Drug Delivery System Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Intranasal Drug Delivery System Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Intranasal Drug Delivery System Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Intranasal Drug Delivery System Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Intranasal Drug Delivery System Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Intranasal Drug Delivery System Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Intranasal Drug Delivery System Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Intranasal Drug Delivery System Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Aptar Pharma Corporation Information Table 43. Aptar Pharma Description and Business Overview Table 44. Aptar Pharma Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 45. Aptar Pharma Intranasal Drug Delivery System Product Table 46. Aptar Pharma Recent Development Table 47. Nemera Corporation Information Table 48. Nemera Description and Business Overview Table 49. Nemera Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 50. Nemera Product Table 51. Nemera Recent Development Table 52. Teleflex Corporation Information Table 53. Teleflex Description and Business Overview Table 54. Teleflex Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 55. Teleflex Product Table 56. Teleflex Recent Development Table 57. Mystic Pharmaceuticals Corporation Information Table 58. Mystic Pharmaceuticals Description and Business Overview Table 59. Mystic Pharmaceuticals Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 60. Mystic Pharmaceuticals Product Table 61. Mystic Pharmaceuticals Recent Development Table 62. Zeteo Medical Corporation Information Table 63. Zeteo Medical Description and Business Overview Table 64. Zeteo Medical Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 65. Zeteo Medical Product Table 66. Zeteo Medical Recent Development Table 67. Johnson & Johnson Corporation Information Table 68. Johnson & Johnson Description and Business Overview Table 69. Johnson & Johnson Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 70. Johnson & Johnson Product Table 71. Johnson & Johnson Recent Development Table 72. GlaxoSmithKline Plc Corporation Information Table 73. GlaxoSmithKline Plc Description and Business Overview Table 74. GlaxoSmithKline Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 75. GlaxoSmithKline Plc Product Table 76. GlaxoSmithKline Plc Recent Development Table 77. Aegis Therapeutics LLC Corporation Information Table 78. Aegis Therapeutics LLC Description and Business Overview Table 79. Aegis Therapeutics LLC Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 80. Aegis Therapeutics LLC Product Table 81. Aegis Therapeutics LLC Recent Development Table 82. H&T Presspart Manufacturing Ltd. Corporation Information Table 83. H&T Presspart Manufacturing Ltd. Description and Business Overview Table 84. H&T Presspart Manufacturing Ltd. Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 85. H&T Presspart Manufacturing Ltd. Product Table 86. H&T Presspart Manufacturing Ltd. Recent Development Table 87. AstraZeneca Plc Corporation Information Table 88. AstraZeneca Plc Description and Business Overview Table 89. AstraZeneca Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 90. AstraZeneca Plc Product Table 91. AstraZeneca Plc Recent Development Table 92. Becton Corporation Information Table 93. Becton Description and Business Overview Table 94. Becton Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 95. Becton Product Table 96. Becton Recent Development Table 97. BD Corporation Information Table 98. BD Description and Business Overview Table 99. BD Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 100. BD Product Table 101. BD Recent Development Table 102. Novartis AG Corporation Information Table 103. Novartis AG Description and Business Overview Table 104. Novartis AG Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 105. Novartis AG Product Table 106. Novartis AG Recent Development Table 107. Vectura Group Plc Corporation Information Table 108. Vectura Group Plc Description and Business Overview Table 109. Vectura Group Plc Intranasal Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 110. Vectura Group Plc Product Table 111. Vectura Group Plc Recent Development Table 112. Key Raw Materials Lists Table 113. Raw Materials Key Suppliers Lists Table 114. Intranasal Drug Delivery System Customers List Table 115. Intranasal Drug Delivery System Distributors List Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Intranasal Drug Delivery System Product Picture Figure 2. Global Intranasal Drug Delivery System Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Intranasal Drug Delivery System Market Size 2017-2028 (US$ Million) Figure 4. Global Intranasal Drug Delivery System Sales 2017-2028 (K Units) Figure 5. United States Intranasal Drug Delivery System Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Intranasal Drug Delivery System Market Size 2017-2028 (US$ Million) Figure 7. United States Intranasal Drug Delivery System Sales 2017-2028 (K Units) Figure 8. United States Intranasal Drug Delivery System Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Intranasal Drug Delivery System Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Intranasal Drug Delivery System Report Years Considered Figure 11. Product Picture of Nasal Drops Figure 12. Product Picture of Nasal Sprays Figure 13. Product Picture of Nasal Gels Figure 14. Product Picture of Nasal Suspensions and Emulsion Figure 15. Product Picture of Nasal Powders Figure 16. Global Intranasal Drug Delivery System Market Share by Type in 2022 & 2028 Figure 17. Global Intranasal Drug Delivery System Sales in Value by Type (2017-2028) & (US$ Million) Figure 18. Global Intranasal Drug Delivery System Sales Market Share in Value by Type (2017-2028) Figure 19. Global Intranasal Drug Delivery System Sales by Type (2017-2028) & (K Units) Figure 20. Global Intranasal Drug Delivery System Sales Market Share in Volume by Type (2017-2028) Figure 21. Global Intranasal Drug Delivery System Price by Type (2017-2028) & (US$/Unit) Figure 22. United States Intranasal Drug Delivery System Market Share by Type in 2022 & 2028 Figure 23. United States Intranasal Drug Delivery System Sales in Value by Type (2017-2028) & (US$ Million) Figure 24. United States Intranasal Drug Delivery System Sales Market Share in Value by Type (2017-2028) Figure 25. United States Intranasal Drug Delivery System Sales by Type (2017-2028) & (K Units) Figure 26. United States Intranasal Drug Delivery System Sales Market Share in Volume by Type (2017-2028) Figure 27. United States Intranasal Drug Delivery System Price by Type (2017-2028) & (US$/Unit) Figure 28. Product Picture of Hospital Figure 29. Product Picture of Clinic Figure 30. Product Picture of Home Care Figure 31. Product Picture of Others Figure 32. Global Intranasal Drug Delivery System Market Share by Application in 2022 & 2028 Figure 33. Global Intranasal Drug Delivery System Sales in Value by Application (2017-2028) & (US$ Million) Figure 34. Global Intranasal Drug Delivery System Sales Market Share in Value by Application (2017-2028) Figure 35. Global Intranasal Drug Delivery System Sales by Application (2017-2028) & (K Units) Figure 36. Global Intranasal Drug Delivery System Sales Market Share in Volume by Application (2017-2028) Figure 37. Global Intranasal Drug Delivery System Price by Application (2017-2028) & (US$/Unit) Figure 38. United States Intranasal Drug Delivery System Market Share by Application in 2022 & 2028 Figure 39. United States Intranasal Drug Delivery System Sales in Value by Application (2017-2028) & (US$ Million) Figure 40. United States Intranasal Drug Delivery System Sales Market Share in Value by Application (2017-2028) Figure 41. United States Intranasal Drug Delivery System Sales by Application (2017-2028) & (K Units) Figure 42. United States Intranasal Drug Delivery System Sales Market Share in Volume by Application (2017-2028) Figure 43. United States Intranasal Drug Delivery System Price by Application (2017-2028) & (US$/Unit) Figure 44. North America Intranasal Drug Delivery System Sales in Volume Growth Rate 2017-2028 (K Units) Figure 45. North America Intranasal Drug Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 46. United States Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. Canada Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. Europe Intranasal Drug Delivery System Sales in Volume Growth Rate 2017-2028 (K Units) Figure 49. Europe Intranasal Drug Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 50. Germany Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. France Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. U.K. Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. Italy Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Russia Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Asia-Pacific Intranasal Drug Delivery System Sales in Volume Growth Rate 2017-2028 (K Units) Figure 56. Asia-Pacific Intranasal Drug Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 57. China Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Japan Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. South Korea Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. India Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Australia Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. China Taiwan Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Indonesia Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Thailand Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Malaysia Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Latin America Intranasal Drug Delivery System Sales in Volume Growth Rate 2017-2028 (K Units) Figure 67. Latin America Intranasal Drug Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 68. Mexico Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Brazil Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 70. Argentina Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Middle East & Africa Intranasal Drug Delivery System Sales in Volume Growth Rate 2017-2028 (K Units) Figure 72. Middle East & Africa Intranasal Drug Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 73. Turkey Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Saudi Arabia Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 75. UAE Intranasal Drug Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 76. Intranasal Drug Delivery System Value Chain Figure 77. Intranasal Drug Delivery System Production Process Figure 78. Channels of Distribution Figure 79. Distributors Profiles Figure 80. Bottom-up and Top-down Approaches for This Report Figure 81. Data Triangulation Figure 82. Key Executives Interviewed
Market Analysis and Insights: Global and United States Intranasal Drug Delivery System Market This report focuses on global and United States Intranasal Drug Delivery System market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Intranasal Drug Delivery System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Nasal Drops accounting for % of the Intranasal Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period. In United States the Intranasal Drug Delivery System market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. Global Intranasal Drug Delivery System Scope and Market Size Intranasal Drug Delivery System market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Intranasal Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028. For United States market, this report focuses on the Intranasal Drug Delivery System market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States. Segment by Type Nasal Drops Nasal Sprays Nasal Gels Nasal Suspensions and Emulsion Nasal Powders Segment by Application Hospital Clinic Home Care Others By Region North America United States Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia UAE By Company Aptar Pharma Nemera Teleflex Mystic Pharmaceuticals Zeteo Medical Johnson & Johnson GlaxoSmithKline Plc Aegis Therapeutics LLC H&T Presspart Manufacturing Ltd. AstraZeneca Plc Becton BD Novartis AG Vectura Group Plc
USD 4350.00
USD 6525.00
USD 8700.00
Add to Cart
Buy Now
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.
In-depth research on key industry players and analysis of production and sales operations.
Objective forecasts of future trends in the industry.
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now